Nanobiotix (NBTX) revenue breakdown
By product, Services is the largest at 77% of fiscal 2025 revenue; Other sales grew fastest, 298% a year over 5 years.
Revenue by product
Fiscal years, as Nanobiotix reports them in its 10-K filings; fiscal 2025 total $30M.
| Products | 2018 | 2019 | 2021 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|
| Services | $109,000 | $40,000 | $5,000 | $30M | -$18M | $23M | 77% |
| Other sales | $7,000 | $28,000 | $5,000 | $308,000 | $6M | $7M | 23% |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for NBTX.
Open NBTX in InvestinglyQuestions
Where does Nanobiotix make its money?
In fiscal 2025, by product: Services $23M, Other sales $7M.
From Nanobiotix's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.